Skip to the page

Data / Form D filings / RENOVION, INC.

RENOVION, INC.: Form D filings

RENOVION, INC., a pharmaceuticals company in Chapel Hill, NC, filed 8 Form D notices with the SEC between 2016 and 2023. The latest, on March 28, 2023, reports $15 million sold of a $15 million offering to 24 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
900 MLK JR. BLVD, SUITE A, Chapel Hill, NC, 27514
Phone
(919) 240-7034
Industry
Pharmaceuticals
Entity type
Corporation
Incorporated in
North Carolina
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1670639

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Mar 28, 2023New notice$15,048,489$15,017,305$31,18424Dec 22, 2022sec.gov
May 29, 2020Amendment$8,099,999$8,099,99943Feb 14, 2020sec.gov
Feb 27, 2020New notice$7,000,000$4,953,045$2,046,9558Feb 14, 2020sec.gov
Feb 7, 2019New notice$800,000$492,196$307,80410Jan 25, 2019sec.gov
May 15, 2018New notice$350,000$350,00012May 2, 2018sec.gov
Jan 17, 2017Amendment$2,051,000$1,868,936$182,06413Aug 11, 2016sec.gov
Aug 30, 2016Amendment$998,863$467,487$531,3766Aug 11, 2016sec.gov
Aug 30, 2016New notice$998,863$467,487$531,3766Jul 12, 2016sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
THOMAS U. BARTONDirector
DEREK W. WINSTANLYDirector
RICHARD W. MATTINGLYDirector
DANIEL W. COPELANDExecutive Officer, Director
JON W. CIVITARESEDirector

Other pharmaceuticals companies in North Carolina that filed recently

Every Form D from the week of Mar 27, 2023 · All recent filings in North Carolina · All recent Pharmaceuticals filings

Read from SEC EDGAR. Amount sold is what RENOVION, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.